Navigation Links
Spanish scientist obtains international award for 3-D video of a journey to the interior of a cicada
Date:9/3/2014

microtomeswhich do not result in the destruction of the insect.

Prof. Alba-Tercedor adds that this technique has "numerous interesting applications" which can be employed "in a large variety of scientific disciplines", such as medicine, anthropology or archaeology, besides zoology itself.

In his own words, Prof. Alba-Tercedor is a "zoologist, specializing in environmentalism and river pollution who has found in microtomography a new exciting area for further multidisciplinary research, which in turn has led to collaborations with research groups all over the world." This current research is part of a larger collaboration project with Dr. Wayne Hunter, from the United States Agriculture Department (USDA) at Fort Pierce, Florida.


'/>"/>

Contact: Javier Alba-Tercedor
jalba@ugr.es
34-958-244-015
University of Granada
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Spanish researcher releases a video showing a beetle from the inside
2. Spanish scientist participate in the most comprehensive study ever done on ice
3. Spanish consumers prefer national fish
4. Spanish researchers design biomarkers for the detection of dengue and West Nile virus
5. A Spanish breakthrough allows the electroporation of cell cultures for less than 1 Euro
6. EAU Patient Information now available in Spanish and Greek
7. Spanish scientists identify a new ancestral enzyme that facilitates DNA repair
8. International patient alliance to fund Spanish Friedreichs ataxia gene-therapy project
9. Spanish slug -- Busting an invasion myth
10. Leading evolutionary scientist to discuss how genome of bacteria has evolved
11. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Spanish scientist obtains international award for 3-D video of a journey to the interior of a cicada
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... Dec. 4, 2014 Increased emphasis on ... in new testing and inspection technologies. The convergence ... to a range of innovative test solutions. This ... Generation Y, which is generally more inclined towards ... product development strategies of test equipment vendors will ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... in the rich tapestry of biochemical signals that cause ... dramatically killed brain cancer cells by blocking those signals ... The unlikely pairing of cholesterol-lowering lovastatin and cyclopamine killed ... By contrast, using either agent alone wiped out ...
... detection of base sequence in duplex nucleic acid has ... "Heteropolymeric Triplex-Based Genomic Assay® to Detect Pathogens or Single-Nucleotide ... issue of the international, peer-reviewed, open access, online journal, ... a wealth of data relating to the assay of ...
... Baylor College of Medicine have discovered a new way to ... to enter cancer cells. , The research appears in the ... , All living cells defend themselves by walling off ... cocoon around the cell's inner machinery and its DNA blueprints. ...
Cached Biology News:Statin plus cancer drug deliver combo punch to brain cancer cells 2Triplex assay used to assay duplex genomic DNA 2Buckyballs used as 'passkey' into cancer cells 2
(Date:12/19/2014)... BioPlus Specialty Pharmacy ... has an expanded team of Regional Pharmaceutical Care ... prescriber offices in their regions, with specific areas ... a variety of Regional Pharmaceutical Care Liaisons specializing ... hepatitis C help prescribers understand all the new ...
(Date:12/19/2014)... 2014 Reports from CDC ... suffer from one or more chronic health conditions - ... can address some of these diseases, but may not ... sufferers face. While implanted nerve stimulation devices today offer ... nerve, which can induce side effects. , To ...
(Date:12/19/2014)... 2014 With only 2 weeks left ... on Sartorius Biohit products . The product specials include ... Electronic Pipette Trade-in Program, and free pipette tips. , ... around the world. They are ideal for lab technicians ... ,     Full volume range of 0.1 uL ...
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced the results ... "This was a transformational year in Relmada,s ... future for our company," said Sergio Traversa , ... we have executed on key financial, human resource and ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... II Study Shows 71% Objective Tumor Response Rate in Evaluable ... Secondary Endpoint Evaluation Shows Promising 7.4 Month Median Progression Free ... Fla. and TUSTIN, Calif., June 1 Peregrine Pharmaceuticals, Inc. ... from a Phase II trial of its lead anti-phosphatidylserine antibody ...
... CHICAGO, June 1 UCB, Inc. and the ... of the 2009 Research Awards in Inflammatory Bowel Disease (IBD) ... research grant for their original clinical or basic research, totaling ... the CDWG Steering Committee and the awards were funded by ...
... today that promising results from ongoing clinical studies in prostate, ... AT-101, an oral, pan-Bcl-2 inhibitor, at the 2009 American Society ... Orlando, Florida. , , (Logo: ... , "We are delighted with the depth and breadth ...
Cached Biology Technology:Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 2Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 3Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 4Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 5Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 6UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows 2Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting 2Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting 4Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting 5
... Recognizes K+ Cl- Cotransporter-1 ... no significant sequence homology ... CCC.,SPECIES REACTIVITIES: The immunogen ... in human, mouse, porcine ...
...
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
oligophrenin-1 (H-100)...
Biology Products: